Advanced search
Publication Cover
Modern Rheumatology Volume 17, 2007 - Issue 6
Journal homepage
49
Views
21
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLE

Efficacy and safety of mizoribine for the treatment of Sjögren's syndrome: a multicenter open-label clinical trial

Shingo NakayamadaFirst Department of Internal Medicine, University of Occupational and Environmental Health,1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
,
Kazuyoshi SaitoFirst Department of Internal Medicine, University of Occupational and Environmental Health,1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, Japan
,
Hisanori UmeharaDepartment of Hematology and Immunology, Kanazawa Medical University,Kahoku, Ishikawa, Japan
,
Noriyoshi OgawaDepartment of Hematology and Immunology, Kanazawa Medical University,Kahoku, Ishikawa, Japan
,
Takayuki SumidaDivision of Clinical Immunology, Major of Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba,Tsukuba, Japan
,
Satoshi ItoDivision of Clinical Immunology, Major of Advanced Biomedical Applications, Graduate School of Comprehensive Human Sciences, University of Tsukuba,Tsukuba, Japan
,
Seiji MinotaDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical School,Shimono, Japan
,
Hiroyuki NaraDivision of Rheumatology and Clinical Immunology, Department of Medicine, Jichi Medical School,Shimono, Japan
,
Hirobumi KondoDepartment of Rheumatology and Infectious Diseases, Kitasato University School of Medicine,Sagamihara, Japan
,
Jun OkadaKitasato University Health Care Center,Sagamihara, Japan
,
Tsuneyo MimoriDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine,Kyoto, Japan
,
Hajime YoshifujiDepartment of Rheumatology and Clinical Immunology, Kyoto University Graduate School of Medicine,Kyoto, Japan
,
Hajime SanoDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine,Nishinomiya, Japan
,
Naoaki HashimotoDivision of Rheumatology, Department of Internal Medicine, Hyogo College of Medicine,Nishinomiya, Japan
,
Susumu SugaiKudoh Hospital,Kaga, Japan
&
Yoshiya TanakaFirst Department of Internal Medicine, University of Occupational and Environmental Health,1-1 Iseigaoka, Yahatanishi-ku, Kitakyushu 807-8555, JapanCorrespondence[email protected]
 show all
Pages 464-469 | Received 16 Feb 2007, Accepted 22 Jun 2007, Published online: 02 Jan 2014

References

  • Mavragani CP, Moutsopoulos NM, Moutsopoulos HM. The man-agement of Sjögren's syndrome. Nat Clin Pract Ftheumatol. 2006;2:252–61.
  • Fox RI. Sjögren's syndrome. Lancet. 2005;366:321–31.
  • Nakayamada S, Saito K, Nakatsuka K, Nakano K, Tokunaga M, Sawamukai N, et al. Efficacy of mizoribine treatment in patients with Sjögren's syndrome: An open trial. Mod Ftheumatol 2003; 13:339–45.
  • Torikai K. Special Issue: New topics on Sj8gren's syndrome. IV. Laboratory tests: 1. Saxon test, gum test, and ophthalmologic exam-inations (in Japanese). Prog Med 2002;22: 43–6.
  • Steinfeld SD, Demols P, Appelboom T. Infliximab in primary Sjögren's syndrome: One-year followup. Arthritis Rheum 2002;46: 3301–3.
  • Mariette X, Ravaud P, Steinfeld S, Baron G, Goetz J, Hachulla E, et al. Inefficacy of infliximab in primary Sj8gren's syndrome: Results of the Randomized, Controlled Trial of Remicade in Primary Sjögren's Syndrome (TRIPSS). Arthritis Rheum 2004;50: 1270–6.
  • Sankar V, Brennan MT, Kok MR, Leakan RA, Smith JA, Manny J, et al. Etanercept in Sjögren's syndrome: A twelve-week random-ized, double-blind, placebo-controlled pilot clinical trial. Arthritis Rheum 2004;50:2240–5.
  • Okubo M, Chen X, Kamata K, Masaki Y, Uchiyama T. Suppressive effect of mizoribine on humoral antibody production in DBA/2 mice. Transplantation 1986;41: 495–8.
  • Turka LA, Dayton J, Sinclair G, Thompson CB, Mitchell BS. Guanine ribonudeotide depletion inhibits T cell activation. J Clin Invest.1991;87:940–8.
  • Brennan F, Plater-Zyberk C, Maini RN, Feldmann M. Coordinate expansion of 'fetal type' lymphocytes (TCRy8.T and CD513) in rheumatoid arthritis and primary Sjögren's syndrome. Clin Exp Immunol 1989;77:175–8.
  • Shiokawa Y, Honma M, Shichikawa K, Miyamoto T, Hirose J, Nobunaga T. Clinical evaluation of the immunosuppressant mizoribine for treatment of rheumatoid arthritis: a multicenter double-blind placebo-controlled trial based on basal treatment(in Japanese). J Clin Expt Med 1991;156:811–31.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.